Figure 4 | British Journal of Cancer

Figure 4

From: Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy

Figure 4

Changes of the immunohistochemical profile of tumours after one cycle of Trastuzumab therapy. (A) Ki67 and GLUT1; (B) HER2, LC3A and LC3B; (C) combined HER2/LC3A and HER2/LC3B. Initial pre-therapy content of HIF1α- (D) and of PgR-positive cells (E) according to response to Trastuzumab plus taxol therapy (bars show standard errors and midline the mean value.

Back to article page